APA (7th ed.) Citation

Barabanshchikova, M. V., Morozova, E. V., Vlasova, Y. Y., Baykov, V. V., Zubarovskaya, L. S., & Afanasyev, B. V. (2016). Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University.

Chicago Style (17th ed.) Citation

Barabanshchikova, M. V., E. V. Morozova, Yu. Yu Vlasova, V. V. Baykov, L. S. Zubarovskaya, and B. V. Afanasyev. Application of Inhibitor JAK1 and JAK2 Ruxolitinib as Pre- and Posttransplant Therapy in Patients with Myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University, 2016.

MLA (8th ed.) Citation

Barabanshchikova, M. V., et al. Application of Inhibitor JAK1 and JAK2 Ruxolitinib as Pre- and Posttransplant Therapy in Patients with Myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University, 2016.